Shares of Option Care Health, Inc. (NASDAQ:OPCH - Get Free Report) have earned a consensus recommendation of "Hold" from the fourteen analysts that are covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and seven have given a buy recommendation to the company. The average 12 month target price among analysts that have covered the stock in the last year is $29.9231.
A number of equities research analysts have issued reports on the stock. Stephens reissued an "equal weight" rating and set a $24.00 target price (down from $30.00) on shares of Option Care Health in a research note on Friday, July 17th. Zacks Research upgraded shares of Option Care Health from a "strong sell" rating to a "hold" rating in a research note on Monday, July 6th. Wall Street Zen raised shares of Option Care Health from a "hold" rating to a "buy" rating in a report on Saturday, August 1st. UBS Group reaffirmed a "buy" rating on shares of Option Care Health in a report on Tuesday, June 16th. Finally, The Goldman Sachs Group started coverage on shares of Option Care Health in a report on Monday, June 8th. They set a "neutral" rating and a $22.00 price objective on the stock.
Read Our Latest Report on Option Care Health
Option Care Health Price Performance
Option Care Health stock opened at $23.64 on Thursday. The company has a market cap of $3.54 billion, a price-to-earnings ratio of 17.77, a PEG ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.91, a quick ratio of 0.98 and a current ratio of 1.47. The firm has a 50 day moving average price of $22.96 and a 200 day moving average price of $24.55. Option Care Health has a 1 year low of $18.01 and a 1 year high of $36.80.
Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings results on Wednesday, July 29th. The company reported $0.45 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.43 by $0.02. Option Care Health had a return on equity of 18.74% and a net margin of 3.68%.The firm had revenue of $1.44 billion during the quarter, compared to the consensus estimate of $1.42 billion. During the same quarter in the previous year, the business earned $0.41 earnings per share. The firm's quarterly revenue was up 1.9% compared to the same quarter last year. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. Sell-side analysts predict that Option Care Health will post 1.69 earnings per share for the current year.
Hedge Funds Weigh In On Option Care Health
Several hedge funds have recently modified their holdings of the stock. Durable Capital Partners LP increased its holdings in shares of Option Care Health by 134.2% during the 2nd quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company's stock worth $267,557,000 after acquiring an additional 4,720,988 shares during the last quarter. Fuller & Thaler Asset Management Inc. raised its stake in Option Care Health by 12.1% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 6,958,800 shares of the company's stock valued at $221,707,000 after purchasing an additional 752,058 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its holdings in shares of Option Care Health by 6.2% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 4,248,425 shares of the company's stock worth $135,355,000 after acquiring an additional 247,118 shares during the period. Dimensional Fund Advisors LP boosted its holdings in shares of Option Care Health by 0.9% in the 1st quarter. Dimensional Fund Advisors LP now owns 3,876,856 shares of the company's stock valued at $104,368,000 after purchasing an additional 36,208 shares in the last quarter. Finally, California State Teachers Retirement System lifted its holdings in shares of Option Care Health by 1,942.1% in the second quarter. California State Teachers Retirement System now owns 3,762,039 shares of the company's stock worth $78,890,000 after acquiring an additional 3,577,818 shares during the last quarter. Institutional investors own 98.05% of the company's stock.
Option Care Health Company Profile
(
Get Free Report)
Option Care Health NASDAQ: OPCH is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.
Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry's most experienced home infusion businesses.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.